Method for the simultaneous quantification of n-hexane metabolites: application to n-hexane metabolism determination

Abstract

1 The described analytical procedure permits the simultaneous determination of the main n-hexane meta bolites in urine. 2-Hexanone, 2-hexanol, 2, 5-hexanediol and 2, 5-hexanedione, were chosen to dose the rats used in this study. All urine samples were collected and analysed on a daily basis, before and after acidic hydrolysis (pH 0.1) by GC/MS. 2-Hexanone, 2, 5-dimethylfurane, γ-valerolac tone and 2, 5-hexanedione were determined before hydro lysis ; 2-hexanol and 2, 5-hexanediol, after hydrolysis; and 5-hydroxy-2-hexanone and 4, 5-dihydroxy-2-hexanone were calculated by the difference between γ-valerolactone and 2, 5-hexanedione with and without hydrolysis, respectively.

2 A metabolic scheme was proposed reflecting the biotransformations undergone by the four compounds assayed. We consider 2, 5-dimethylfurane as a 'true metabolite' because the quantities detected were always greater before hydrolysis.

3 It has been reported that human and rat n-hexane metabolism follow a similar pattern. Therefore, as a practical application and without increasing either sample or time requirements, the simultaneous quantifi cation of the different metabolites and their excretion profile could provide better information about the metabolic situation of exposed workers than the determi nation of 2, 5-hexanedione alone. According to our experimental results, 4, 5-dihydroxy-2-hexanone itself would be a good toxicity indicator.

Keywords

n-hexane 2,5-hexanodione metabolism urine bio- marker

Get full access to this article

View all access options for this article.

References

Kurita H.

Experimental studies of the effects of n-hexane to albino rats. Japanese Journal of Industrial

Health 1967; 9: 672-677.

Miyagaki H.

Electrophysiological studies on the peripheral neurotoxicity of n-hexane. Japanese Journal Industrial

Health 1967; 9: 660-671.

Fromer U. , Ullirich V. , Orrenius S. Influence of inducers and inhibitors on the hydroxylation pattern of n-hexane in rat liver microsomes. Febs Letters 1974 ; 41: 14-16.

Di Vincenzo GD , Kaplan CJ , Dedinas J. Characterization of the metabolites of methyl-n-butylketone, methyl-iso-butylketone and methylethylketone in guinea pig serum and their clearance. Toxicology and Applied Pharmacology 1976; 36: 511-522.

Di Vincenzo GD , Hamilton ML , Kaplan CJ , Dedinas J. Metabolic fate and disposition of 14C-labeled methyl-n-butyl ketone in the rat. Toxicology and Applied Pharmacology 1977; 41: 547-560.

Fedtke N. , Bolt MH The relevance of 4, 5-dihydroxy-2-hexanone in the excretion of n-hexane metabolites in rat and man. Archives of Toxicology 1987 ; 61: 131-137.

Spencer PS , Schaumburg HH , Sabri MH , Veronesi B. The enlarging view of hexacarbon neurotoxicity. Critical Reviews in Toxicology 1980; 3: 278-356.

Di Vincenzo GD , Krasavage WJ , O'Donoghue JL Role of metabolism in hexacarbon neuropathy. The Scientific Basis of Toxicity Assessment. Witschi (ed.) Elsevier North-Holland: Biomedical Press 1980; pp. 183-200.

Misumi J. , Nagano M. , Nomura S. An experimental study on the neurotoxicity of 2-octanone and 2-hexanol, a metabolite of n-hexane. Japanese Journal of Industrial Health 1982; 24: 475-484.

10.

Misumi J. , Nagano M. Neurophysiological studies on the relation between the structural properties and neurotoxicity of aliphatic hydrocarbon compounds in rats. British Journal of Industrial Medicine 1984; 41: (4), 526-532.

11.

Nachtman JP , Couri D. An electrophysiological study of 2-hexanone and 2, 5-hexanedione neurotoxicity in rats. Toxicology Letters 1984; 23: 141-145.

12.

Couri D. , Milks MM Hexacarbon neuropathy: Tracking a toxin. Neurotoxicology 1985; 6: 65-72.

13.

Perbellini L. , Brugnone F. , Silvestri R. , Gaffuri E. Measurement of the urinary metabolites of n-hexane, cyclohexane and their isomers by gas chromatography. International Archives of Occupational and Environmental Health 1981a; 48: 99-106.

14.

Perbellini L. , Brugnone F. , Faggionato G. Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. British Journal of Industrial Medicine 1981b; 38: 20-26.

15.

Fedtke N. , Bolt HM Methodological investigations on the determination of n-hexane metabolites in urine. International Archives of Occupational and Environmental Health 1986a; 57: 149-158.

16.

Fedtke N. , Bolt HM Detection of 2, 5-hexanedione in the urine of persons not exposed to n-hexane . International Archives of Occupational and Environmental Health 1986b; 57: 143-148.

17.

Eben A. et al. Toxicological and metabolic studies of methyl n-butylketone, 2, 5-hexanedione, and 2, 5-hexanediol in male rats. Ecotoxicology and Environmental Safety 1979; 3: 204-217.

18.

Krasavage WJ , O'Donoghue JL , Di Vicenzo DG , Terhaar CJ The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicology and Applied Pharmacology 1980; 52: 433-441.

19.

Iwata M. , Takeuchi Y. , Hisanaga N. , Ono Y. A study on biological monitoring of n-hexane exposure. International Archives of Occupational and Environmental Health 1983; 51: 253-260.

20.

Mutti A. et al. n-Hexane metabolism in occupationally exposed workers. British Journal of Industrial Medicine 1984; 41: 533-538.

21.

De Rosa E. et al. Environmental and biological monitoring of exposure to toluene, styrene, and n-hexane. Applied Industrial Hygiene 1988; 3: 332-337.

22.

Ahonen I. , Schimberg RW 2, 5-Hexanedione extraction after occupational exposure to n-hexane . British Journal of Industrial Medicine 1988 ; 45: 133-136.

23.

Imbriani M. , Gehittori S. , Pezaagno G. , Capodeglio E. n-Hexane urine elimination and weighted exposure concentration. International Archives of Occupational and Environmental Health 1984; 55: 33-41.

24.

Cert A. , Bahima J.

Head-space sampling and GC analysis of volatile urinary metabolites. Journal of Chromatographic

Science 1984; 22: 7-11.

25.

Baker TS , Rickert DE Dose-dependent uptake, distribution and elimination of inhalated n-hexane in the Fischer-344 rat. Toxicology and Applied Pharmacology 1981; 61: 414-422.

26.

Perabellini L. , Amantini ML , Brugnone F. , Frontali M. Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Archives of Toxicology 1982; 50: 203-215.

27.

Perbellini L. , Brugnone F. , Pavan I. Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. Toxicology and Applied Pharmacology 1980; 53: 220-229.

28.

De Carpio AP , Olajos EJ , Weber P. Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2, 5-hexanedione. Toxicology and Applied Pharmacology 1982; 65: 440-450.

29.

De Carpio AP , Briggs RG , Jackowski SJ , Kim JC Comparative neurotoxicity and pyrrole-forming potential of 2, 5-hexanedione and predeuterio-2, 5-hexanedione in rat. Toxicology and Applied Pharmacology 1988; 92: 75-85.

30.

Genter MB et al. Evidence that pyrrole formation is a pathogenetic step in γ-diketone neuropathy. Toxicology and Applied Pharmacology 1987; 87: 351-362.

31.

De Carpio AP , O'Neil EA. Alterations in rat axonal cyto-skeletal proteins induced by in vitro and in vivo 2, 5-hexanedione exposure. Toxicology and Applied Pharmacology 1985; 78: 235-247.

32.

Saito I. et al. Determination of urinary 2, 5-hexanedione concentration by an improved analytical method as an index of exposure to n-hexane. British Journal of Industrial Medicine 1991; 48: 568-574.